Methanesulfonyl chloride → HCID 66884465, compound
Reaction equation
[CH:1]12[NH:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][CH:3]([NH:9][C:10]([N:12]1[CH2:16][CH2:15][C@@H:14]([NH:17][C:18]3[CH:23]=[CH:22][C:21]([C:24]#[N:25])=[CH:20][N:19]=3)[CH2:13]1)=[O:11])[CH2:2]2.CCN(C(C)C)C(C)C.[CH3:35][S:36](Cl)(=[O:38])=[O:37]>C(Cl)Cl.CC(O)=O.CO>[C:24]([C:21]1[CH:22]=[CH:23][C:18]([NH:17][C@@H:14]2[CH2:15][CH2:16][N:12]([C:10]([NH:9][CH:3]3[CH2:4][CH:5]4[N:8]([S:36]([CH3:35])(=[O:38])=[O:37])[CH:1]([CH2:7][CH2:6]4)[CH2:2]3)=[O:11])[CH2:13]2)=[N:19][CH:20]=1)#[N:25]Participants
7
Procedure
To a stirred solution of (3R)—N-(8-azabicyclo[3.2.1]octan-3-yl)-3-(5-cyanopyridin-2-ylamino)pyrrolidine-1-carboxamide (18 mg, 0.053 mmol) and i-Pr2NEt (0.075 mL, 0.4 mmol) in CH2Cl2 (1 mL) was added methanesulfonyl chloride (0.008 mL, 0.10 mmol). The mixture was stirred overnight at rt, diluted with HOAc (0.1 mL) and MeOH (0.9 mL) and purified by prep HPLC to afford the title compound (13 mg, 58%). LC-MS Method 1 tR=1.1 min, m/z=419; 1H NMR (CD3OD) [selected resonances] 2.93 (s, 3H), 4.47 (m, 1H), 6.78 (d, 1H), 7.77 (d, 1H), 8.40 (s, 1H)
Workup
- custompurified by prep HPLC
Sources & evidence
- ORD record
- ord-ff74afed80d443a2bc589dd4fd90c2d2
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08828985B2
Reaction notes
Loading…